As previously suggested in studies examining FMR1 mRNA toxicity in mosaic FXS cases with FXTAS phenotypes [60, 61], bulk mRNA analysis averages out levels between cells that overexpress mRNA and cells that have mRNA completely silenced. The gene discussed is FMR1; the disease is fragile X syndrome.